Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Tempus AI

Tempus AI Expands Into Digital Pathology With Paige Acquisition

Tempus AI, Inc. (NASDAQ:TEM) stock is trading higher on Friday after acquiring Paige, an AI company specializing in digital pathology.

Benzinga

Cathie Wood's $21 Million Tuesday Move: Peter Thiel's Crypto Play Gets Boost In Ark Portfolio

Cathie Wood-led Ark Invest made significant trades on Tuesday with notable activity in Bullish (NYSE:BLSH), Robinhood Markets Inc. (NASDAQ:HOOD), and Tempus AI Inc. (NASDAQ:TEM).

Benzinga

Trump Says Nancy Pelosi Traded On Inside Information—Her 2025 Portfolio Outperforms S&P 500 Thanks To These 4 Stocks

President Donald Trump has accused former House Speaker Nancy Pelosi of trading on “inside information” after her portfolio’s returns reportedly outperformed the SP 500 in 2025.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Cathie Wood's Top 10 Stock Picks: Unpacking Ark Funds Innovation Picks For The Next Decade

Ark Invest CEO Cathie Wood is known for her stock picks over the last decade, handpicking many of the growth stocks that find their way into the company's ETFs.

Benzinga

Tempus AI’s Strong Q2 Fuels Growth Story—More Upside Ahead?

Tempus AI fired on all cylinders in Q2, and Morgan Stanley upgraded the stock. What is the near and long-term outlook for this name, up 89% in 2025?

MarketBeat

Tempus AI Raises Outlook, CEO Cites Faster-Than-Expected Growth And Improved Margins

Tempus AI Inc. (NASDAQ:TEM) reported second-quarter financial results Friday.

Benzinga

Tempus AI Gears Up For Q2 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts

Tempus AI, Inc. (NASDAQ:TEM) will release earnings results for the second quarter before the opening bell on Friday, Aug. 8.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Palantir, Nvidia & Tempus AI Could Be Pharma ETF Darlings That Don't Make Pills

Imagine this: a hospital conference room, lights low, filled with decision-makers. A sales representative clicks through slides driven by Palantir Technologies’ (NASDAQ:PLTR) Foundry platform, highlighting real-time data integration and pinpoint analytics that would make Pharma RD from the past look like it’s still sending lab results by fax. Down the…

Benzinga

Cathie Wood's Ethereum Double-Down: Ark Bets $7.9 Million On ETH-Staking ETF Buy While Selling Coinbase At Highs

On Wednesday, Cathie Wood-led Ark Invest executed significant trades, including substantial purchases in Tempus AI Inc. (NASDAQ:TEM), NVIDIA Corp. (NASDAQ:NVDA), 3iQ Ether Staking ETF (ETHQ.U) and Coinbase Global Inc. (NASDAQ:COIN).

Benzinga

Tempus AI Stock Is Rising Wednesday: What's Happening?

Tempus AI Inc (NASDAQ:TEM) shares are trading higher Wednesday after the company announced that it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its ejection fraction software.

Benzinga

Cathie Wood Bets Another $1 Million On Tempus AI Despite Jim Cramer's Doubts, Dumps Crypto Stocks As Bitcoin Hits Fresh New Highs

On Thursday, Cathie Wood-led Ark Invest made significant trades involving Tempus AI Inc. (NASDAQ:TEM), Coinbase Global Inc. (NASDAQ:COIN), Robinhood Markets Inc. (NASDAQ:HOOD), and Block Inc. (NYSE:XYZ).

Benzinga

Cathie Wood Vs. Jim Cramer: TV Host Says Top Ark AI Pick 'Losing Money Hand Over Fist'

When it comes to artificial intelligence stocks, there are multiple that are found in the various portfolios of Ark Funds, led by Cathie Wood.

Benzinga

Cramer Says Tesla Dominates While Ouster Is 'Too Speculative'

In a market increasingly defined by volatility and uncertainty, investors are grappling with a mix of opportunities and risks. The recent turmoil in the tech sector, particularly among companies heavily reliant on artificial intelligence, has raised questions about sustainability and profitability.

Benzinga

Cathie Wood Dumps Jack Dorsey's Block As Bitcoin Flirts With All-Time Highs, Bets $8.8 million On Tempus AI

On Wednesday, the Cathie Wood-led Ark Invest made a significant move by purchasing a substantial number of shares in Tempus AI Inc. (NASDAQ:TEM) and selling shares of Block Inc. (NYSE:XYZ). The trades were executed through the ARKG and ARKK ETFs.

Benzinga

Get all your
news in one place.

100’s of premium titles.
One news app.

Barchart

Short Sellers Are Taking Aim at Buy-Rated Tempus AI. Should You Buy TEM Stock Here?

Tempus AI stock fell over 19% after Spruce Point Capital released a short report. Can TEM stock recover?

Kiplinger

5 Momentum Stocks to Buy Now

Amid volatile trade and rising uncertainty, these momentum stocks have shown strong signs of leadership in the first half of 2025.

MarketBeat

Tempus AI Stock: Time to Double Down or Cut and Run?

Tempus AI is gaining traction and on track for profits this year; high short interest and rising institutional activity point to significant upside potential.

MarketBeat

3 Hot New IPOs Defying the 2025 Market Slump

Tempus AI, ServiceTitan, and CoreWeave are 2025 IPO standouts, defying a down market. Here’s how they’re beating the S&P 500 so far this year.

Get all your
news in one place.

100’s of premium titles.
One news app.

International Business Times UK

Nancy Pelosi's 2025 Stock Buys Worth $1.95M are Deep in Red, Some as Much as 57%

Former House Speaker Nancy Pelosi purchased call option contracts of companies, including Alphabet, Amazon, Nvidia, Vistra Corp, and Tempus AI, in January.

MarketBeat

4 Healthcare Stocks With Massive Gains—and More to Come

Healthcare is the top industry of 2025 so far. These healthcare companies have seen 30% increases in share prices since the beginning of the year.

International Business Times UK

Nancy Pelosi's Net Worth Has Dropped By £11.23M After Trump Took Office

Nancy Pelosi's investments in top tech giants have markedly declined after Trump's tariff plans introduced volatility in stock markets.

Barchart

Cathie Wood Loves This Under-the-Radar AI Stock. Is It Time for You to Buy Now?

MarketBeat

Tempus AI Is a Buy, If You Can Handle the Volatility

Tempus AI is well-positioned to capitalize on its extensive clinical data database. It can provide personalized treatment for hard-to-treat illness.

International Business Times UK

Nancy Pelosi's Tempus AI Stock Investment Jumps Over 300% in 40 Days

Pelosi's Tempus AI call options contracts tripled in value in 40 days as the healthcare firm continued its upward rally on AI-product launches and active collaborations to battle diseases like cancer.

MarketBeat

Conflicting Signals: Tempus AI's Stock Market Rally

Tempus AI's stock has soared on completed acquisitions and product launches, yet mixed analyst sentiment signals a need for careful investor review.

1 2 3

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Artificial Intelligence

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.